Proventix Systems, Inc. announces that through working with Founders Investment Banking, LLC, it has completed a growth capital funding round with a strategic investor. Headquartered in Birmingham, Ala., Proventix delivers a multimodal solution to the healthcare industry that improves caregiver hand hygiene compliance and reduces instances of healthcare-associated infections (HAIs) among patients. Utilizing RFID technology, Proventix leads with a data-centric approach which delivers valuable data, compelling clinical results, and broad operational benefits to clients. Recognized as a pioneer and industry leader in the growing infection control space, Proventix plans to use this investment to execute on the company's aggressive growth plans and to support both domestic and international distribution agreements.
"By implementing a data-driven approach with role-based analytics and individualized feedback, our team has been able to successfully address the keystone event tied to HAIs as well as generate sustainable results for clients," says Harvey Nix, founder and CEO of Proventix. "Education is critical to improving hand hygiene compliance, and our strategy has been to influence the clinical culture through positive reinforcement and actionable intelligence. This method secures support at all levels of the organization and also produces a clear and measureable ROI from a financial and human capital standpoint. This capital, coupled with a value-added partner, will allow us to expedite several growth initiatives as well as formalize key partnerships that will broaden Proventix's reach."
Zane Tarence, managing director of Founders' Technology Practice says, "Our team was especially impressed with the technology foundation and differentiated strategy that Proventix employed. Harvey and his team's leadership position in the infection control space give them an advantage over competitors who have only a handful of implementations and devote minimal time to understanding long-term clinical sustainability. With a continued shift towards outcome-based funding, hospitals are highly incentivized to address HAIs, and Proventix is well positioned to meet this highly personal and growing need. The company has a unique opportunity to meaningfully impact how care is delivered, and the Founders team is excited to watch Harvey and the Proventix team execute on this strategy."
Source: Proventix Systems, Inc.; Founders Investment Banking, LLC
The Guardians of Animal Health: Who Are Veterinary Infection Preventionists?
March 21st 2025Veterinary infection control experts Leslie Kollmann, BS, AAS, CVT, CIC, Denise Waiting, LVT, and Leslie Landis, LVT, BS, discuss challenges, zoonotic disease risks, and the importance of education, collaboration, and resource development in animal care facilities.
The Latest on CLABSIs and CAUTIs: Evidence-Based Approaches for Infection Prevention
February 27th 2025Health care–associated infections like CLABSIs and CAUTIs threaten patient safety. Learn evidence-based strategies, new technologies, and prevention protocols to reduce these infections and improve outcomes.
Resilience and Innovation: The Pivotal Contributions of Black Americans to Health Care and Medicine
February 24th 2025During Black History Month, we honor the resilience and contributions of Black medical professionals in health care. Despite barriers, they have led transformative changes, advocating for equitable access and medical excellence. Recognizing their impact ensures a more inclusive health care future for all.
Glove Usage Guideline: From The Joint Commission, CDC, and World Health Organization
February 17th 2025Proper glove use is crucial in health care settings to prevent infections. Guidelines from TJC, CDC, and WHO stress correct selection, usage, and disposal to minimize health care–associated infections (HAIs) and cross-contamination risks. Infection preventionists (IPs) play a key role in educating staff, enforcing compliance, and improving patient safety through standardized glove practices.